Artificial Intelligence (AI) in Biotechnology Market is anticipated to witness High Growth owing to increasing R&D
Artificial Intelligence (AI) In Biotechnology Market Artificial intelligence (AI) in biotechnology refers to the use of machine learning and deep learning algorithms to interpret large and complex biomolecular and healthcare datasets. AI is empowering the digital transformation of biotech & pharma industries by speeding up drug discovery, accelerating genomic research and enabling precision medicine. The global AI in biotechnology market is estimated to be valued at US$ 7.11 Bn in 2024 and is expected to exhibit a CAGR of 19% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the AI in biotechnology market are AstraZeneca, Bristol-Myers Squibb, Gilead Sciences, Inc., Sanofi, Abbott Laboratories, Biogen, Pfizer, Inc., Novo Nordisk A/S, Amgen, Inc., Merck KGaA, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Deep Genomics, NVIDIA Corporation, Verge Genomics, Recursion Pharmaceuticals. These players are adopting ...